Nyumbani › Amyloidosis
Majaribio ya kliniki ya Amyloidosis yanayovutia washiriki nchini Marekani
Masomo 29 ya Amyloidosis yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Boston, MAUtafiti 11
- Rochester, MNUtafiti 10
- New York City, NYUtafiti 10
- Dallas, TXUtafiti 9
- Philadelphia, PAUtafiti 7
- Houston, TXUtafiti 6
- Baltimore, MDUtafiti 6
- Portland, ORUtafiti 6
- Durham, NCUtafiti 6
- St. Louis, MOUtafiti 6
- Cleveland, OHUtafiti 5
- San Diego, CAUtafiti 5
- Chicago, ILUtafiti 5
- Washington, DCUtafiti 5
- Nashville, TNUtafiti 5
- Richmond, VAUtafiti 4
- Los Angeles, CAUtafiti 4
- Jacksonville, FLUtafiti 4
- Detroit, MIUtafiti 4
- Charlotte, NCUtafiti 4
- Seattle, WAUtafiti 4
- San Francisco, CAUtafiti 4
- Indianapolis, INUtafiti 3
- Columbus, OHUtafiti 3
- Arlington, VAUtafiti 3
- Charleston, SCUtafiti 3
- Mountain View, CAUtafiti 3
- Atlanta, GAUtafiti 3
- New Haven, CTUtafiti 3
- Kansas City, MOUtafiti 3
- Edison, NJUtafiti 3
- Kansas City, KSUtafiti 3
- Aurora, COUtafiti 3
- Miami, FLUtafiti 3
- Salt Lake City, UTUtafiti 3
- Austin, TXUtafiti 3
Kwa jimbo
- ArizonaUtafiti 3
- CaliforniaUtafiti 8
- ColoradoUtafiti 5
- ConnecticutUtafiti 4
- FloridaUtafiti 8
- GeorgiaUtafiti 3
- IllinoisUtafiti 5
- IndianaUtafiti 3
- KansasUtafiti 3
- MarylandUtafiti 7
- MassachusettsUtafiti 11
- MichiganUtafiti 5
- MinnesotaUtafiti 10
- MissouriUtafiti 7
- New JerseyUtafiti 3
- New YorkUtafiti 10
- North CarolinaUtafiti 10
- OhioUtafiti 6
- OregonUtafiti 6
- PennsylvaniaUtafiti 7
- South CarolinaUtafiti 4
- TennesseeUtafiti 7
- TexasUtafiti 11
- UtahUtafiti 3
- VirginiaUtafiti 4
- WashingtonUtafiti 4
- Wilaya ya ColumbiaUtafiti 4
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07285044A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 130 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
InaajiriHatua 3
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
InaajiriHatua 3
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT07358078Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
InaajiriUtafiti wa uchunguzi
Umri wote · Wanawake · Imesasishwa 8 Sep 2026 · NCT05040373ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT04561518Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Inaajiri
Umri 65 na zaidi · Jinsia zote · Imesasishwa 1 Sep 2026 · NCT05577819Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
InaajiriUtafiti wa uchunguzi
Umri 30 hadi 80 · Jinsia zote · Imesasishwa 31 Ago 2026 · NCT05489549Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT05145816Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
InaajiriHatua 3
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 4 Ago 2026 · NCT06563895Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
InaajiriHatua 4
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 29 Jul 2026 · NCT07695701A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
InaajiriHatua 1Wajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Jul 2026 · NCT05951816[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Jul 2026 · NCT07560306A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Jul 2026 · NCT07224672A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Jul 2026 · NCT07081646Dietary Reporting In The Amyloidoses
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 26 Jun 2026 · NCT05738005Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
InaajiriHatua 1
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 19 Mei 2026 · NCT06974877A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Mei 2026 · NCT06158854Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
InaajiriHatua 2
Umri 40 hadi 90 · Jinsia zote · Imesasishwa 13 Apr 2026 · NCT05758493MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
InaajiriHatua 3
Umri 18 hadi 90 · Jinsia zote · Imesasishwa 27 Mac 2026 · NCT06128629Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
InaajiriUtafiti wa uchunguzi
Umri 30 hadi 80 · Jinsia zote · Imesasishwa 7 Jan 2026 · NCT07196839Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 31 Des 2025 · NCT04991103A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
InaajiriUtafiti wa uchunguzi
Umri 20 na zaidi · Jinsia zote · Imesasishwa 26 Des 2025 · NCT07216469Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.